524768 — Emmessar Biotech and Nutrition Balance Sheet
0.000.00%
Last trade - 00:00- IN₹138.89m
- IN₹67.48m
- IN₹6.11m
Annual balance sheet for Emmessar Biotech and Nutrition, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | — | — |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 25.2 | 47.1 | 52.9 | 64.4 | 71.4 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 27.1 | 0.32 | 0.91 | 2.05 | 0.483 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 53.9 | 48.6 | 59.3 | 68.3 | 74.1 |
| Net Property, Plant And Equipment | 12.3 | 14.6 | 14 | 13.1 | 12.2 |
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 78.1 | 72.1 | 79.4 | 87.4 | 92.2 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 14 | 3.3 | 4.2 | 5.04 | 4.72 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 21.1 | 10.4 | 12.8 | 13.4 | 15.1 |
| Common Stock | |||||
| Other Equity | |||||
| Total Equity | 57 | 61.7 | 66.6 | 74 | 77.1 |
| Total Liabilities & Shareholders' Equity | 78.1 | 72.1 | 79.4 | 87.4 | 92.2 |
| Total Common Shares Outstanding |